81 related articles for article (PubMed ID: 17855479)
1. P2 purinoceptor-mediated cardioprotection in ischemic-reperfused mouse heart.
Wee S; Peart JN; Headrick JP
J Pharmacol Exp Ther; 2007 Dec; 323(3):861-7. PubMed ID: 17855479
[TBL] [Abstract][Full Text] [Related]
2. Involvement of P2Y receptors in pyridoxal-5'-phosphate-induced cardiac preconditioning.
Millart H; Alouane L; Oszust F; Chevallier S; Robinet A
Fundam Clin Pharmacol; 2009 Jun; 23(3):279-92. PubMed ID: 19453760
[TBL] [Abstract][Full Text] [Related]
3. KR-31762, a novel KATP channel opener, exerts cardioprotective effects by opening SarcKATP channels in rat models of ischemia/reperfusion-induced heart injury.
Lee SH; Yang MK; Lim JH; Seo HW; Yi KY; Yoo SE; Lee BH; Won HS; Lee CS; Choi WS; Shin HS
Arch Pharm Res; 2008 Apr; 31(4):482-9. PubMed ID: 18449506
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological profiles of cloned mammalian P2Y-receptor subtypes.
von Kügelgen I
Pharmacol Ther; 2006 Jun; 110(3):415-32. PubMed ID: 16257449
[TBL] [Abstract][Full Text] [Related]
5. Protecting murine hearts from ischaemia-reperfusion using selective inhibitors of adenosine metabolism.
Willems L; Headrick JP
Clin Exp Pharmacol Physiol; 2005 Mar; 32(3):179-83. PubMed ID: 15743400
[TBL] [Abstract][Full Text] [Related]
6. Effects of adenosine deaminase and A1 receptor deficiency in normoxic and ischaemic mouse hearts.
Willems L; Reichelt ME; Molina JG; Sun CX; Chunn JL; Ashton KJ; Schnermann J; Blackburn MR; Headrick JP
Cardiovasc Res; 2006 Jul; 71(1):79-87. PubMed ID: 16626672
[TBL] [Abstract][Full Text] [Related]
7. Activation of kappa-opioid receptors at reperfusion affords cardioprotection in both rat and mouse hearts.
Peart JN; Gross ER; Reichelt ME; Hsu A; Headrick JP; Gross GJ
Basic Res Cardiol; 2008 Sep; 103(5):454-63. PubMed ID: 18500486
[TBL] [Abstract][Full Text] [Related]
8. The nitric oxide-releasing naproxen derivative displays cardioprotection in perfused rabbit heart submitted to ischemia-reperfusion.
Rossoni G; Manfredi B; Del Soldato P; Berti F
J Pharmacol Exp Ther; 2004 Aug; 310(2):555-62. PubMed ID: 15082750
[TBL] [Abstract][Full Text] [Related]
9. Modulation of firing activity by ATP in dopamine neurons of the rat substantia nigra pars compacta.
Choi YM; Jang JY; Jang M; Kim SH; Kang YK; Cho H; Chung S; Park MK
Neuroscience; 2009 May; 160(3):587-95. PubMed ID: 19272429
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological properties of ATP-sensitive purinergic receptors expressed in human G292 osteoblastic cells.
Li DL; Liu X; Xia R; Ross C; Yang X; Jiang LH
Eur J Pharmacol; 2009 Sep; 617(1-3):12-6. PubMed ID: 19577559
[TBL] [Abstract][Full Text] [Related]
11. Activation of purinergic receptors by ATP induces ventricular tachycardia by membrane depolarization and modifications of Ca2+ homeostasis.
Gurung IS; Kalin A; Grace AA; Huang CL
J Mol Cell Cardiol; 2009 Nov; 47(5):622-33. PubMed ID: 19679135
[TBL] [Abstract][Full Text] [Related]
12. Insulin inhibits beta-adrenergic action in ischemic/reperfused heart: a novel mechanism of insulin in cardioprotection.
Yu QJ; Si R; Zhou N; Zhang HF; Guo WY; Wang HC; Gao F
Apoptosis; 2008 Feb; 13(2):305-17. PubMed ID: 18165901
[TBL] [Abstract][Full Text] [Related]
13. Adenosine-mediated cardioprotection in ischemic-reperfused mouse heart.
Peart J; Flood A; Linden J; Matherne GP; Headrick JP
J Cardiovasc Pharmacol; 2002 Jan; 39(1):117-29. PubMed ID: 11743234
[TBL] [Abstract][Full Text] [Related]
14. Uridine-5'-triphosphate protects against hepatic- ischemic/reperfusion injury in mice.
Ben-Ari Z; Pappo O; Yitzhaki S; Cheporko Y; Shainberg A; Zinman T; Ravid A; Zemel R; Bachmatov L; Kurtzwald E; Mor E; Hochhauser E
Transplantation; 2009 Apr; 87(8):1155-62. PubMed ID: 19384161
[TBL] [Abstract][Full Text] [Related]
15. [Ischemic postconditioning protects hypertrophic myocardium by ERK1/2 signaling pathway: experiment with mice].
Li XM; Ma YT; Yang YN; Zhang JF; Chen BD; Liu F; Huang Y; Han W; Gao XM
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(12):846-50. PubMed ID: 19595127
[TBL] [Abstract][Full Text] [Related]
16. Extracellular NAADP affords cardioprotection against ischemia and reperfusion injury and involves the P2Y11-like receptor.
Djerada Z; Peyret H; Dukic S; Millart H
Biochem Biophys Res Commun; 2013 May; 434(3):428-33. PubMed ID: 23583195
[TBL] [Abstract][Full Text] [Related]
17. Age-related changes in ischemic tolerance in male and female mouse hearts.
Willems L; Zatta A; Holmgren K; Ashton KJ; Headrick JP
J Mol Cell Cardiol; 2005 Feb; 38(2):245-56. PubMed ID: 15698831
[TBL] [Abstract][Full Text] [Related]
18. Modulation of neurotransmitter release by P2X and P2Y receptors in the rat spinal cord.
Heinrich A; Kittel A; Csölle C; Sylvester Vizi E; Sperlágh B
Neuropharmacology; 2008 Feb; 54(2):375-86. PubMed ID: 18063000
[TBL] [Abstract][Full Text] [Related]
19. Preconditioning with acute and chronic lithium administration reduces ischemia/reperfusion injury mediated by cyclooxygenase not nitric oxide synthase pathway in isolated rat heart.
Faghihi M; Mirershadi F; Dehpour AR; Bazargan M
Eur J Pharmacol; 2008 Nov; 597(1-3):57-63. PubMed ID: 18789320
[TBL] [Abstract][Full Text] [Related]
20. Functional evidence for purinergic inhibitory neuromuscular transmission in the mouse internal anal sphincter.
McDonnell B; Hamilton R; Fong M; Ward SM; Keef KD
Am J Physiol Gastrointest Liver Physiol; 2008 Apr; 294(4):G1041-51. PubMed ID: 18308858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
